Replies to post #188171 on Amarin Corp Plc (AMRN)

[Invest83838]

Time Will Tell the Truth


We are all just speculating at this point.

All we can do at the moment is just postulate

revenue and net income based on estimated future script sales

I hope I am wrong but:

AMRN has yet to report even one quarter of positive net income;

AMRN still has quite a bit of debt that needs to be paid off over time;

AMRN will need to ramp up sales quicker than they currently are so they will need more sales people, which will increase expenses;

As Vascepa sales increase, the raw material costs may increase due to supply & demand considerations;

AMRN has a history of share dilution to fund expansions; and

AMRN Management has a history of rewarding themselves "free" shares and options for shares.

Since I still have my 128,000 shares, I sincerely hope Amarin is very successful whether they GIA of have a BO

But I believe that more Vascepa will be sold before the patents expire if "the right BP" takes over ASAP,

obtains quicker FDA approval since they have inroads with FDA,

quickly markets Vascepa in all sort of ways since they have the money and the experience to do so, and

ensures raw material supply is "locked-in" at a reasonable price for the duration before patents expire,

as well as adequate processing facilities setup in time,

since they have experience and relationships with industry that Amarin does not.